GLP-1s are driving returns on R&D investments for Big Pharma, report says
Big Pharma is expected to see big returns from its investment in a class of drugs made famous by Novo Nordisk’s (NVO) popular ...
MM&M4d
What did Big Pharma CEOs get paid in 2024?
Zepbound’s Q4 sales coincided with the FDA removing tirzepatide — the drug’s active ingredient — off the official shortage list in December. Subsequently, the pharma giant announced ... Sahin’s big ...
Big pharma fears best-selling drugs in crosshairs of US-EU tariff spat
Drugmakers are urging the Trump administration and European Union officials to exclude medical goods from expanding tariff ...
Medical Dialogues1d
307 Cases of Drug Price Violations Surface, Big Pharma To Face Heat?
The issue of drug pricing violations has come under scrutiny, with the Parliamentary Standing Committee on Chemicals and ...
Big pharma fears drug price spikes in US-EU tariff spat, Reuters says
Drugmakers are urging the Trump administration and European Union officials to exclude medical goods from the tariff wars, Maggie Fick of ...
Big tech meets biotech: Recursion and the AI gold rush in pharma
The use of AI in drug discovery and development has been recognised, explored, and implemented throughout the last decade, ...
Politico9d
A look at the tax benefits for pharma ads
The estimate is based on what drug companies would pay to the U.S ... and solutions to discourage or tax Big Pharma’s DTC advertising,” CSRxP executive director Lauren Aronson said in a ...